Abstract
Background Cigarette smoking is a leading modifiable cardiovascular disease risk factor. Cross-sectional studies demonstrated variable relations of smoking behavior with measures of vascular function. Additionally, the impact of persistent versus changes in smoking behaviors on alterations in central arterial function is unclear.
Methods and Results We assessed associations of smoking behavior and intensity with measures of central arterial hemodynamics in 6597 participants (51.5% never smoked, 34.8% formerly quit, 4.3% recent quit, and 9.3% currently smoking) of the Framingham Heart Study (N=3606 [55%] women). In cross-sectional models, central vascular measures were different across categories of smoking behavior. For example, augmentation index was higher among participants who formerly quit smoking (least squares mean±standard error=14.1±0.4%; P<0.001) and were currently smoking (18.1±0.5%; P<0.001) compared to participants who never smoked (12.6±0.3%). Among participants who were currently smoking, higher cigarettes per day (estimated B=1.41; 95% CI, 0.47—2.34; P=0.003) was associated with higher augmentation index. Among participants who had quit smoking, higher pack-years was associated with higher augmentation index (est. B=0.85; 95% CI, 0.60—1.14) and central pulse pressure (est. B=0.84; 95% CI, 0.46—1.21). Using restricted cubic splines, we observed a negative linear association for augmentation index, but a distinct nonlinear association for characteristic impedance and central pulse pressure, with higher time since quit (all P<0.001). In longitudinal models, we observed higher increases in augmentation index among participants who persistently quit (4.62±0.41%; P<0.001) and persistently smoked (5.48±0.70%; P=0.002) compared to participants who persistently never smoked (3.45±0.37%).
Conclusion Central arterial measures are sensitive to smoking status and intensity and changes in smoking behavior. Longer smoking cessation may partially revert central arterial measures to levels comparable to those with lower smoking exposure.
Competing Interest Statement
G.F.M. is owner of Cardiovascular Engineering, Inc., a company that designs and manufactures devices that measure vascular stiffness. The company uses these devices in clinical trials that evaluate the effects of diseases and interventions on vascular stiffness. G.F.M. also serves as a consultant to and receives grants and honoraria from Novartis, Merck, Bayer, Servier, Philips, and deCODE genetics. The remaining authors have no disclosures to report.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All protocols were approved by the Boston University Medical Center’s Institutional Review Board (https://www.bumc.bu.edu/irb/), and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
